Residential College | false |
Status | 已發表Published |
Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival | |
Haapasalo A.1; Koponen E.1; Hoppe E.2; Wong G.1![]() | |
2001 | |
Source Publication | Biochemical and Biophysical Research Communications
![]() |
ISSN | 0006291X |
Volume | 280Issue:5Pages:1352-1358 |
Abstract | Truncated trkB.T1 (TI) neurotrophin receptor inhibits full-length trkB.TK+ (TK+) signaling. At least two possible mechanisms have been proposed for this action: T1 could trap the ligand or function as a dominant negative receptor. To differentiate between these possibilities we have studied survival of serum-deprived PC12-trkB cells stably expressing TK+. PC12-trkB cells were observed to display constitutive trkB kinase activity which leads to survival of a cell subpopulation in the absence of added brain-derived neurotrophic factor (BDNF) and serum. Exogenous BDNF significantly increased cell survival, and this increase was inhibited by BDNF neutralizing antibody. The antibody treatment had no effect on the constitutive TK+ activity. Transfected T1 completely inhibited survival by BDNF or constitutive trkB kinase activity in PC12-trkB cells similarly to tyrosine kinase inhibitor K252a. In addition, T1 coimmunoprecipitated with TK+ and inhibited its autophosphorylation by BDNF. These data suggest that truncated T1 inhibits TK+ signaling by dominant negative action. © 2001 Academic Press. |
Keyword | Bdnf K252a N2a Cell Pc12 Cell Tyrosine Phosphorylation |
DOI | 10.1006/bbrc.2001.4296 |
URL | View the original |
Language | 英語English |
WOS ID | WOS:000167128500023 |
Scopus ID | 2-s2.0-0034816219 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | Faculty of Health Sciences |
Affiliation | 1.Itä-Suomen yliopisto 2.Sanofi-Aventis Deutschland GmbH |
Recommended Citation GB/T 7714 | Haapasalo A.,Koponen E.,Hoppe E.,et al. Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival[J]. Biochemical and Biophysical Research Communications, 2001, 280(5), 1352-1358. |
APA | Haapasalo A.., Koponen E.., Hoppe E.., Wong G.., & Castren E. (2001). Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival. Biochemical and Biophysical Research Communications, 280(5), 1352-1358. |
MLA | Haapasalo A.,et al."Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival".Biochemical and Biophysical Research Communications 280.5(2001):1352-1358. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment